Kallischnigg Gerd, Weitkunat Rolf, Lee Peter N
Philip Morris Products S,A,, PMI Research & Development, Neuchâtel, Switzerland.
BMC Oral Health. 2008 May 1;8:13. doi: 10.1186/1472-6831-8-13.
How smokeless tobacco contributes to non-neoplastic oral diseases is unclear. It certainly increases risk of oral mucosal lesions, but reviewers disagree as to other conditions. In some areas, especially South-East Asia, risk is difficult to quantify due to the many products, compositions (including non-tobacco ingredients), and usage practices involved. This review considers studies from Europe (in practice mainly Scandinavia) and from the USA.
Experimental and epidemiological studies published in 1963-2007 were identified that related risk of oral lesions to smokeless tobacco use. Data were assessed separately for oral mucosal lesions, periodontal and gingival diseases, dental caries and tooth loss, and oral pain.
Oral mucosal lesions: Thirty-three epidemiological studies consistently show a strong dose-related effect of current snuff on oral mucosal lesion prevalence. In Scandinavia, users have a near 100% prevalence of a characteristic "snuff-induced lesion", but prevalence of the varied lesions reported in the USA is lower. Associations with chewing tobacco are weaker. The lack of clear association with former use suggests reversibility following cessation, consistent with experimental studies showing rapid lesion regression on quitting.Periodontal and gingival diseases: Two of four studies report a significant association of snuff with attachment loss and four out of eight with gingival recession. Snuff is not clearly related to gingivitis or periodontal diseases. Limited evidence suggests chewing tobacco is unrelated to periodontal or gingival diseases.Tooth loss: Swedish studies show no association with snuff, but one US study reported an association with snuff, and another with chewing tobacco.Dental caries: Evidence from nine studies suggests a possible relationship with use of smokeless tobacco, particularly chewing tobacco, and the risk of dental caries.Oral pain: Limited evidence precludes any clear conclusion.
This review confirms the strong association of current use of smokeless tobacco, particularly snuff, with prevalence of oral mucosal lesions. It provides suggestive evidence of an association of snuff use with gingival recession and attachment loss, and of chewing tobacco with dental caries. While smokeless tobacco clearly increases risk of oral mucosal lesions, interpretation for other endpoints is limited by study weaknesses, including poor confounding control.
无烟烟草如何导致非肿瘤性口腔疾病尚不清楚。它肯定会增加口腔黏膜病变的风险,但对于其他病症,评论者们存在分歧。在一些地区,尤其是东南亚,由于涉及多种产品、成分(包括非烟草成分)和使用习惯,风险难以量化。本综述考虑了来自欧洲(实际上主要是斯堪的纳维亚)和美国的研究。
确定了1963年至2007年发表的将口腔病变风险与无烟烟草使用相关联的实验性和流行病学研究。分别评估了口腔黏膜病变、牙周和牙龈疾病、龋齿和牙齿脱落以及口腔疼痛的数据。
口腔黏膜病变:33项流行病学研究一致表明,当前使用鼻烟对口腔黏膜病变患病率有强烈的剂量相关效应。在斯堪的纳维亚,使用者中特征性“鼻烟引起的病变”患病率接近100%,但美国报告的各种病变患病率较低。与咀嚼烟草的关联较弱。与既往使用缺乏明确关联表明戒烟后病变具有可逆性,这与实验研究显示戒烟后病变迅速消退一致。
四项研究中的两项报告鼻烟与附着丧失有显著关联,八项研究中的四项报告鼻烟与牙龈退缩有关联。鼻烟与牙龈炎或牙周疾病没有明确关联。有限的证据表明咀嚼烟草与牙周或牙龈疾病无关。
瑞典的研究表明与鼻烟没有关联,但一项美国研究报告与鼻烟有关联,另一项与咀嚼烟草有关联。
九项研究的证据表明与无烟烟草使用,特别是咀嚼烟草使用以及龋齿风险之间可能存在关系。
证据有限,无法得出明确结论。
本综述证实了当前使用无烟烟草,特别是鼻烟与口腔黏膜病变患病率之间的强烈关联。它提供了鼻烟使用与牙龈退缩和附着丧失以及咀嚼烟草与龋齿之间存在关联的提示性证据。虽然无烟烟草明显增加了口腔黏膜病变的风险,但对于其他终点的解释因研究缺陷而受到限制,包括混杂控制不佳。